NASDAQ:MASI • US5747951003
The current stock price of MASI is 175.35 USD. In the past month the price increased by 28.7%. In the past year, price decreased by -7.11%.
ChartMill assigns a technical rating of 7 / 10 to MASI. When comparing the yearly performance of all stocks, MASI turns out to be only a medium performer in the overall market: it outperformed 60.84% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to MASI. Both the profitability and the financial health of MASI get a neutral evaluation. Nothing too spectacular is happening here.
Over the last trailing twelve months MASI reported a non-GAAP Earnings per Share(EPS) of 5.68. The EPS increased by 54.77% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -31.33% | ||
| ROE | -70.3% | ||
| Debt/Equity | 0.69 |
16 analysts have analysed MASI and the average price target is 180.21 USD. This implies a price increase of 2.77% is expected in the next year compared to the current price of 175.35.
For the next year, analysts expect an EPS growth of 31.03% and a revenue growth -27.07% for MASI
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 20.26 | 202.318B | ||
| ISRG | INTUITIVE SURGICAL INC | 49.26 | 178.812B | ||
| SYK | STRYKER CORP | 25.62 | 148.172B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.94 | 113.97B | ||
| IDXX | IDEXX LABORATORIES INC | 44.32 | 52.44B | ||
| BDX | BECTON DICKINSON AND CO | 11.2 | 50.281B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.08 | 50.178B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.78 | 38.406B | ||
| RMD | RESMED INC | 20.87 | 37.332B | ||
| DXCM | DEXCOM INC | 29.08 | 28.639B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. The company is headquartered in Irvine, California and currently employs 3,600 full-time employees. The company went IPO on 2007-08-08. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. The company primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
MASIMO CORP
52 Discovery
Irvine CALIFORNIA 92618 US
CEO: Joe Kiani
Employees: 3600
Phone: 19492977000
Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. The company is headquartered in Irvine, California and currently employs 3,600 full-time employees. The company went IPO on 2007-08-08. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. The company primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
The current stock price of MASI is 175.35 USD. The price increased by 0.07% in the last trading session.
MASI does not pay a dividend.
MASI has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
The Revenue of MASIMO CORP (MASI) is expected to decline by -27.07% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
MASIMO CORP (MASI) currently has 3600 employees.
MASIMO CORP (MASI) has a market capitalization of 9.42B USD. This makes MASI a Mid Cap stock.